Filter
135
Text search:
foodborne
bacteria
Featured
Recommendations
10
New Publications
26
Language
Document type
No document type
46
Studies & Reports
37
Guidelines
24
Strategic & Response Plan
12
Manuals
8
Fact sheets
4
Training Material
3
Situation Updates
1
Countries / Regions
Global
5
Western and Central Europe
4
Kenya
3
Africa
3
Nigeria
2
Ethiopia
2
India
2
Western Pacific Region
2
Sierra Leone
1
USA
1
Ghana
1
Zimbabwe
1
Philippines
1
Germany
1
Zambia
1
Thailand
1
Bangladesh
1
Peru
1
North Macedonia
1
Myanmar / Burma
1
South–East Asia Region
1
Laos
1
Latvia
1
Authors & Publishers
Publication Years
Category
Key Resources
22
Countries
18
Clinical Guidelines
11
Capacity Building
4
Public Health
4
Women & Child Health
2
Pharmacy & Technologies
2
Toolboxes
AMR
52
Planetary Health
24
HIV
8
Cholera
6
Rapid Response
6
Global Health Education
6
2.0 Rapid Response
6
Natural Hazards
5
Ebola & Marburg
2
TB
2
Refugee
1
Specific Hazards
1
COVID-19
1
Caregiver
1
NTDs
1
This paper focuses on the Sustainable Development Goals related to poverty, economic growth, inequality, health, food production and the environment. It presents concrete examples of the underlying and complex aspects of antibiotic resistance and its impacts across different Sustainable Development
...
A guide for practical implementation in adult and pediatric emergency department and urgent care settings
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the
...
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2020 in 27 EU Member States (MS) and nine non-MS. Key statistics on zoonoses and zoonotic agents in humans, food, animals and feed are provided and interpreted historically.
Journal of The Association of Physicians of India, Vol. 63 November 2015,, pp.77-96
This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in line with the
strategic objectives of the Glo
...
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in
...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in
...
Manual for Early Implementation
In Climate Change 2014: Impacts, Adaptation, and Vulnerability. Part A: Global and Sectoral Aspects. Contribution of Working Group II to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (HIV) and the pathogens that cause mala
...
